Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 14 » default
ESCI
Impact Factor
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (136)
- Volume 14, 2024 (3)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 14, 2024
Review
Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date
Rega F, Trovato F, Bortone G, Pellacani G, Richetta AG, Dattola A
Psoriasis: Targets and Therapy 2024, 14:23-27
Published Date: 15 March 2024
Original Research
Experiences of Dermatologists and Patients Regarding Psoriasis and Its Connection to Psoriatic Arthritis in Saudi Arabia
Fatani MI, Al-homood I, Bedaiwi M, Al Natour S, Erdogan A, Alsharafi A, Attar SM
Psoriasis: Targets and Therapy 2024, 14:11-22
Published Date: 18 January 2024
Review
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
Osman A, Nigro A, Taylor AC, Saal R, Ormaza Vera A, Enos C
Psoriasis: Targets and Therapy 2024, 14:1-10
Published Date: 10 January 2024